Hyloris Pharmaceuticals SA

ENXTBR:HYL Stock Report

Market Cap: €310.8m

Hyloris Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HYL?
Owner TypeNumber of SharesOwnership Percentage
Institutions102,0640.365%
General Public12,270,70543.8%
Individual Insiders15,627,60555.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.


Top Shareholders

Top 12 shareholders own 56.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.4%
Stijn Van Rompay
10,202,034€113.2m0%no data
13.1%
Thomas Jacobsen
3,657,505€40.6m0%no data
6.17%
Bart Versluys
1,727,623€19.2m0%no data
0.15%
Mandarine Gestion
42,500€471.7k0%0.02%
0.1%
Degroof Petercam Asset Management
28,975€321.6k0%no data
0.086%
Aramea Asset Management AG
24,127€267.8k0%0.05%
0.071%
Dietmar Aichhorn
20,000€222.0k0%no data
0.062%
Koenraad Van Der Elst
17,443€193.6k0%no data
0.015%
Dimensional Fund Advisors LP
4,246€47.1k81.5%no data
0.011%
Jean-Luc Vandebroek
3,000€33.3k0%no data
0.0071%
Claresco Finance
2,000€22.2k0%0.01%
0.00077%
State Street Global Advisors, Inc.
216€2.4k10.8%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.